Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Greenwich LifeSciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 21 | 22 | +1 |
| Shares | 792.9K | 671.4K | −121.5K (−15.3%) |
| Value | $7.21M | $10.2M | +$2.99M (+41.4%) |
New holders (3)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 12,778 | $194.0K | 0.02% |
| 683 Capital Management, LLC | 11,700 | $177.8K | 0.02% |
| Tower Research Capital LLC (TRC) | 52 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Pura Vida Investments, LLC | 19,667 | $179.0K |
| HRT Financial LP | 12,029 | $109.0K |